| Literature DB >> 36016849 |
Riden Saxena1, Kriti Shrinet2,3, Sachchida Nand Rai4, Kamal Singh5,6, Shivi Jain7, Shuchi Jain1, Deeksha Singh1, Shampa Anupurba5, Madhu Jain1.
Abstract
Female genital tuberculosis (FGTB) can be asymptomatic or even masquerade as other gynecological conditions. Conventional methods of FGTB diagnosis include various imaging, bacteriological, molecular, and pathological techniques that are only positive in a small percentage of patients, leaving many cases with undiagnosed condition. In the absence of a perfect diagnostic method, composite reference standards (CRSs) have been advocated in this diagnostic study. This study assesses the agreement between traditional diagnostic modalities using CRS and prevalent TB groups among different fallopian tube infertility manifestations. A total of 86 women with primary and secondary infertility were included in the study and subjected to bacteriological, pathological, and radiological examination for the diagnosis of FGTB. Results were evaluated statistically for concordance of the diagnostic tests to the CRS by sensitivity and specificity, while PPV and NPV were calculated for the performance of diagnostic tests of FGTB. We observed that 11.2% of women were found to be true positives by means of CRS. The positive findings by CRS were as follows: ultrasonography (13.9%), laparoscopy (14%), hysteroscopy (12%), GeneXpert (4.8%), culture (4.8%), polymerase chain reaction (4.8%), and histopathology (6.4%). GeneXpert and culture were found to have a perfect agreement with CRS. Hysterosalpingography, laparoscopy, and hysteroscopy have a fair agreement with CRS. Out of 43 women with tubal factor infertility, 6 women were found in the definitive TB group with mixed conditions of tubal manifestations. This study evaluates and demonstrates the reliability of the collective assessment of various diagnostic methods with CRS findings that help in identifying different TB groups of genital tuberculosis patients from all infertile patients by applying the criteria of CRS.Entities:
Mesh:
Year: 2022 PMID: 36016849 PMCID: PMC9398877 DOI: 10.1155/2022/8078639
Source DB: PubMed Journal: Dis Markers ISSN: 0278-0240 Impact factor: 3.464
Figure 1Representative laparoscopic view and arrows showing caseous nodules in FGTB case.
Figure 2Representative granulomatous inflammation on histopathology showing well-formed granuloma with giant cell at center surrounded by epitheloid cells and lymphocytes, outermost surrounded by fibroblasts.
Performance of the Imaging methods for the diagnosis of FGTB: sensitivity, specificity, and kappa agreement in comparison with composite reference standards.
| USG | CRS | HSG | CRS | ||
|---|---|---|---|---|---|
| 12/62 | TB group ( | Non-TB group (n =54) | 16/43 | TB group ( | Non-TB group ( |
| Positive ( | 6 | 6 | Positive ( | 5 | 11 |
| Negative ( | 2 | 48 | Negative ( | 1 | 26 |
| Sensitivity | 80.00%, (95% CI: 44.39% to 97.48%) | Sensitivity | 85.71% (95% CI: 42.13% to 99.64%) | ||
| Specificity | 88.89%, (95% CI: 77.37% to 95.81%) | Specificity | 70.27% (95% CI: 53.02% to 87.13%) | ||
| PPV | 57.14%, (95% CI: 37.10% to 75.09%) | PPV | 35.29%, (95% CI: 23.39% to 49.26%) | ||
| NPV | 96.00%, (95% CI: 87.81% to 98.77%) | NPV | 96.30%, (95% CI: 80.71% to 99.38%) | ||
| Kappa value (95% CI) | Agreement | Level of agreement | Kappa value (95% CI) | Agreement | Level of agreement |
| 0.52 (0.24 to 0.81) | 72.74% | Moderate | 0.31 (0.053 to 0.57) | 59.22% | Fair |
PPV: positive predictive value; NPV: negative predictive value; TB group: TB-suspected patients; PCR: polymerase chain reaction; CRS: composite reference standard. For patients with suspicion of FGTB, diagnosis of TB was given if any two of culture/histopathology/radiological findings were positive.
Performance of the Imaging endoscopic methods for the diagnosis of FGTB: sensitivity, specificity, and kappa agreement in comparison with composite reference standards.
| Laparoscopy | CRS | Hysteroscopy | CRS | ||
|---|---|---|---|---|---|
| 19/50 | TB group ( | Non-TB group ( | 15/50 | TB group ( | Non-TB group ( |
| Positive ( | 5 | 14 | Positive ( | 5 | 10 |
| Negative ( | 2 | 29 | Negative ( | 1 | 34 |
| Sensitivity | 77.78% (95% CI: 39.99% to 97.19%) | Sensitivity | 85.71% (95% CI: 42.13% to 99.64%) | ||
| Specificity | 67.44% (95% CI: 51.46% to 80.92%) | Specificity | 77.27% (95% CI: 62.16% to 88.53%) | ||
| PPV | 33.33% (95% CI: 22.32% to 46.53%) | PPV | 37.50% (95% CI: 24.34% to 52.81%) | ||
| NPV | 93.55% (95% CI: 80.76% to 98.04%) | NPV | 97.14% (95% CI: 84.61% to 99.53%) | ||
| Kappa value (95% CI) | Agreement | Level of agreement | Kappa value (95% CI) | Agreement | Level of agreement |
| 0.22 (-0.015 to 0.468) | 58.64% | Fair | 0.36 (0.09 to 0.64) | 65.20% | Fair |
Figure 3Gel image of amplified PCR product of MPT64 gene. M: marker 100 bp; PC: positive control (H37Rv); lanes 2, 4, and 5: positive band for Mycobacterium tuberculosis (mpt64 gene); lanes 1 and 3: negative for mpt64 gene; and NC: negative control (PCR grade water).
Performance of the bacteriology for the diagnosis of FGTB: sensitivity, specificity, and kappa agreement in comparison with composite reference standards.
| GeneXpert | CRS | Culture | CRS | ||
|---|---|---|---|---|---|
| 3/62 | TB group ( | Non-TB group ( | 3/62 | TB group ( | Non-TB group ( |
| Positive ( | 3 | 0 | Positive ( | 3 | 0 |
| Negative ( | 0 | 59 | Negative ( | 0 | 59 |
| Sensitivity | 100.00% (95% CI: 29.24% to 100.00%) | Sensitivity | 100.00% (95% CI: 29.24% to 100.00%) | ||
| Specificity | 100.00% (95% CI: 93.94% to 100.00%) | Specificity | 100.00% (95% CI: 93.94% to 100.00%) | ||
| PPV | 100.00% | PPV | 100.00% | ||
| NPV | 100.00% | NPV | 100.00% | ||
| Kappa value (95% CI) | Agreement | Level of agreement | Kappa value (95% CI) | Agreement | Level of agreement |
| 1.0 (1.0 to 1.0) | 90.79% | Perfect | 1.0 (1.0 to 1.0) | 90.79% | Perfect |
Performance of the PCR and HPE for the diagnosis of FGTB: sensitivity, specificity, and kappa agreement in comparison with composite reference standards.
| PCR | CRS | HPE | CRS | ||
|---|---|---|---|---|---|
| 5/62 | TB group ( | Non-TB group ( | 4/62 | TB group ( | Non-TB group ( |
| Positive ( | 3 | 2 | Positive ( | 3 | 1 |
| Negative ( | 0 | 57 | Negative ( | 1 | 57 |
| Sensitivity | 100.00% (95% CI: 29.24% to 100.00%) | Sensitivity | 75% (95% CI: 19.41% to 99.37%) | ||
| Specificity | 96.61% (95% CI: 88.29% to 99.59%) | Specificity | 98.28% (95% CI: 90.76% to 99.96%) | ||
| PPV | 60.00% (95% CI: 27.75% to 85.42%) | PPV | 75.00% (95% CI: 28.29% to 95.78%) | ||
| NPV | 100.00% | NPV | 99.28% (95% CI: 91.26% to 99.68%) | ||
| Kappa value (95% CI) | Agreement | Level of agreement | Kappa value (95% CI) | Agreement | Level of agreement |
| 0.73 (0.38 to 1.0) | 87.88% | Substantial | 0.73 (0.37 to 1.0) | 87.93% | Substantial |
Findings of fallopian tube TB suspected infertility patients and clinical assessment of patients on the basis of composite reference standard (CRS) criteria.
| Hysterosalpingogram | Clinical assessment of patients(CAP) | ||||
|---|---|---|---|---|---|
| Definitive TB groups | Probable TB groups | Possible TB groups | Non-TB groups | Total | |
| CRS or GeneXpert or culture | PCR or history + imaging suggestive for FGTB | Imaging suggestive to FGTB | Negative for all tests | ||
| Calcifications | — | 1 | 2 | 1 | 4 |
| Tubal outline irregular | 1 | 1 | 2 | — | 4 |
| Tubal occlusion | 2 | 2 | 3 | 1 | 8 |
| Tubal dilation | 2 | — | 2 | — | 4 |
| Peritubal adhesion | — | 1 | 2 | — | 3 |
| Calcifications+ tubal outline irregular | — | 1 | — | 1 | 2 |
| Calcifications+ tubal outline irregular+ tubal occlusion | — | 1 | 2 | — | 3 |
| Tubal occlusion+ peritubal adhesion | — | 1 | 1 | — | 2 |
| Tubal occlusion+ tubal outline irregular | — | — | 1 | 1 | 2 |
| Tubal occlusion+ calcifications+ peritubal adhesion | — | — | 1 | — | 1 |
| Tubal occlusion+ tubal dilation | 1 | 1 | 2 | 4 | |
| Tubal outline irregular+ peritubal adhesion | — | 1 | 1 | 2 | |
| Tubal dilation+ calcifications (hydrosalpinx) | — | — | 1 | 1 | 2 |
| Normal spills | — | 1 | 1 | — | 2 |
| Total | 6 | 10 | 21 | 6 | 43 |
Figure 4Diagnostic algorithm for FGTB. ESR: erythrocyte sedimentation rate; CBC: complete blood count; USG: ultrasonography; HSG: hysterosalpingograpgy; LAP: laparoscopy; HYS: hysteroscopy; PCR: polymerase chain reaction; HPE: histopathology; and CRS: composite reference standard.
Clinical findings in patients of genital tuberculosis by using CRS.
| Patients no. | Methods | Findings |
|---|---|---|
| OBG19RS 14 | USG, HSG, hysteroscopy, GeneXpert, culture, PCR | Diffused endometrial border, dilated tube, hydrosalpinx, GeneXpert positive, culture positive, PCR positive |
| OBG19RS 23 | USG, HSG, laparoscopy, hysteroscopy, GeneXpert, culture, PCR | Beaded tubes, intrauterine adhesion, GeneXpert positive, culture positive, PCR positive with rifampicin resistant, caseous nodules |
| OBG19RS 38 | History, USG, HSG, laparoscopy, hysteroscopy, GeneXpert, culture, PCR | Localized peritoneal spill with tubal occlusion, GeneXpert positive, culture positive, PCR positive, tubercular nodules |
| OBG19RS 40 | History, USG, HSG, laparoscopy, hysteroscopy | Bilateral tubal dilation, pyosalpinx |
| OBG19RS 44 | USG, HSG, laparoscopy, HPE | Tubal occlusion and dilation, cornual block |
| OBG19RS 49 | USG, HSG, laparoscopy, hysteroscopy, HPE | Outline irregular, visualized endometrial disease-like tubercles |
| OBG19RS 58 | History, USG, laparoscopy, hysteroscopy, HPE | Intrauterine adhesions, heterogeneous endometrium with irregular surface, epithelial granulomatous nodules |
| OBG19RS 59 | USG, laparoscopy, HPE | Endometritis, lesions on uterus like tubercles, caseous nodules |
Figure 5(a) HSG showing right hydrosalpinx and left cornual block; (b) HSG showing irregular uterine cavity with a localized peritoneal spill on the right and tubal occlusion on left; (c) HSG showing irregular and deformed uterine cavity with mild right hydrosalpinx; and (d) HSG showing normal uterine cavity and fallopian tubes without any peritoneal spill.